Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global cervical cancer treatment market attained a value of USD 7.24 billion in 2023. The market is expected to grow further at a CAGR of 6.4% during the forecast period of 2024-2032 to attain a value of USD 12.65 billion by 2032, driven by the rising prevalence of the disease across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cervical cancer is the type of cancer that starts in the cervix, which is a part that connects the vagina to the uterus. Women over the age of thirty are more vulnerable to the risk of cervical cancer. Cervical cancer mostly happens to women who are sexually active and is caused due to the transmission of a virus called human papillomavirus (HPV) during sexual activities. While most of the women the virus at some point of their lives, only some of those women get cervical cancer. The virus does not show any significant symptoms, so the chances are that women who have it, would not even know. It only becomes a problem when it stay for a longer period and leads to the development of cancer cells in the cervical. Other than this virus, other factors that lead to higher chances of cervical cancer include HIV and tobacco consumption.
The main diagnostic methods for the disease include HPV vaccine and screening tests and the early the tests are done, the higher is the chance of survival. Although the cancer is easily treatable, it needs to be detected as early as possible for effective treatment, that ensures that the patient can lead a healthy life after the treatment. The possibility of recurrence is also less if the treatment is done well. The most effective way of preventing the possibility of having cervical cancer is to get HPV vaccine to minimise or eradicate the chances of cervical, vulvar, and vaginal cancers. These vaccinations can be taken in different age groups and can be started from as early as 9 years. If not as early as 9 years, this vaccine can also be taken in the older age with doctor’s advice in different shots. The chances of prevention, however, decrease as the person ages without the vaccination. Moreover, the vaccine can also reduce the chances of tumours in the future and not treat any existing tumour in the body. For this reason, it is important to get regular screening done in order to detect any existing cancer.
In case the cancer spreads to other tissues or organs, the symptoms can get worse. The severe symptoms would include painful urination, presence of blood in urine, pain in rectum or bleeding in rectum. Other symptoms can be fatigue, loss of appetite, severe weight loss, perennial backache, swelling in the legs, pain in pelvic or abdominal region, among others.
These are two major diagnostic methods in the market currently:
The Pap Test/ Pap Smear- This test helps in identifying precancers or cancer cells that start developing in the cervical. In the test, cells are collected from the cervix to detect cancer in the cervix. The early detection of the cancer helps in getting early treatment. It is recommended for women to get these tests done every three years between the age group of 21-65.
HPV Test- This test detects the presence of HPV virus in the cervix and can help reduce the chances of getting cervical cancer if the virus is killed at the initial stage only.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The cervical cancer treatment market can be categorised into segments like stage, tests, cell type, product type, treatment channels, and regions.
Market Breakup by Stage
Market Breakup by Tests
Market Breakup by Cell Type
Market Breakup by Product Type
Market Breakup by Treatment Channel
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cervical cancer is among the leading types of cancer amongst women. In 2020, the number of cervical cancer cases was close to 604000 and the death rate reached 342000. According to the estimates by American Cancer Society, nearly 13,960 more cases of cervical cancer will be diagnosed in 2024 and the death toll will reach close to 4,310 by 2024. Earlier, the number of deaths due to cervical cancer was extremely high in the United States but the numbers have now reduced significantly reduced due to the rising use of available tests like Pap test and HPV test due to the rising awareness.
The prevalence of cervical cancer is highest amongst older women, especially in the age group of 35-45. The possibility of having cervical cancer increases with age, about 20% of women are diagnosed with cancer when they are over the age of 65. Women under the age of 20 are less vulnerable to the disease.
Cervical cancer can be efficiently treated, if diagnosed early. The current treatment methods for cervical cancer include the following methods:
Radiation Therapy- This therapy uses beams or radiations to eliminate the cancer cells, The two therapies included in the market are External beam radiation therapy (EBRT) and Brachytherapy.
Chemotherapy- This method uses drugs to attack the tumour cells. These drugs are either given in injection or taken orally. The treatment is done in various cycles and the dose, and the length of treatment depends upon the grade and location of the cancer.
Surgery- There are various surgeries available for the treatment of cervical cancer. These surgeries include laser surgery, cryosurgery, cone biopsy, simple hysterectomy, radical hysterectomy with pelvic lymph node dissection, trachelectomy, and pelvic exenteration.
Targeted Therapy- This therapy attacks the cancer cells without affecting the healthy cells. The drugs target the proteins that control the spread of the cells.
Immunotherapy- This therapy comprises the use of drugs to boost the immunity cells to fight the cancer cells.
There are numerous studies which are currently under trials, some of these ongoing trials are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Stage |
|
Breakup by Tests |
|
Breakup by Cell Type |
|
Breakup by Product Type |
|
Breakup by Treatment Channel |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
In 2023, the market attained a value of nearly USD 7.24 billion.
The market is projected to grow at a CAGR of 6.4% during the forecast period of 2024-2032.
The market is estimated to witness healthy growth during the forecast period of 2024-2032 to reach a value of USD 12.65 billion by 2032.
The growth of the market is driven by factors like rising prevalence of the disease, rapid technological advancements, availability of non-invasive therapies, and rising expenditure on healthcare.
The key trends in the market include rising research and development, along with the rising awareness about the availability and effectiveness of available treatment.
The stages of cervical cancer can be categorised into stage 0, 1, 2, 3, and 4.
The tests used for the diagnosis of the tumour include pap smear test procedure, colposcopy procedure, and ecc procedure, among others.
The market can be divided on the basis of cell type into adenocarcinoma, squamous cell carcinoma, and adenosquamous carcinoma.
The treatment channels can be categorised into public and private.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major players in the market are F. Hoffmann-LA Roche AG, Merck & Co., Inc., GlaxoSmithKline Plc., Allergan Inc. (AbbVie, Inc.), Biocon Limited, Pfizer Inc., Eli Lilly and Company, Hologic Inc., Qiagen N.V., Quest Diagnostics Inc., Dickinson and Co., and Bio-Rad Laboratories Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124